À̸ÞÀÏ: jerald2r@lycos.com ȨÆäÀÌÁö: http://http://www.c5designs.com/about-c5
I"ll call back later <a href=" http://www.cresthillsuites.com/corporate-info/ ">augmentin 1g amoxicillin trihydrate</a> On June 30, Onyx rejected the unsolicited Amgen bid of $120a share - a premium of about 38 percent to the company"s shareprice. Onyx said it would consider other potential buyers andits shares have since soared nearly 47 percent. On Thursday,sources familiar with the matter said that Pfizer Inc had decided not to pursue a competing bid, leaving Amgen in thepole position for a takeover and shares of Onyx fell back to the$128 range.
|
|